Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance

European Journal of Medicinal Chemistry
2018.0

Abstract

Twenty-four novel β-carboline/acylhydrazone hybrids were synthesized and evaluated for their in vitro antiproliferative activity. Among them, 12r exhibited the most potent activity, with IC50 values of 1-2 μM against panel of cancer cell lines and retained significant activity in multidrug resistant cancer cells. Treated cells were not arrested in any phase of cell cycle but resulted in late cellular apoptosis on both MCF-7 and MCF-7/ADR cancer cells. Importantly, 12r showed certain antitumor effect on inhibiting the tumor growth with low toxic and side effects and without significant body weight loss.

Knowledge Graph

Similar Paper

Discovery of novel β-carboline/acylhydrazone hybrids as potent antitumor agents and overcome drug resistance
European Journal of Medicinal Chemistry 2018.0
β-Carboline and N-hydroxycinnamamide hybrids as anticancer agents for drug-resistant hepatocellular carcinoma
European Journal of Medicinal Chemistry 2019.0
Synthesis and evaluation of novel hybrids β -carboline-4-thiazolidinones as potential antitumor and antiviral agents
European Journal of Medicinal Chemistry 2016.0
Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives
Bioorganic & Medicinal Chemistry 2011.0
Design, synthesis and anticancer evaluation of tetrahydro-β-carboline-hydantoin hybrids
Bioorganic & Medicinal Chemistry Letters 2014.0
Design and Synthesis of Novel β‐Carboline‐Bisindole Hybrids as Potential Anticancer Agents
ChemMedChem 2024.0
Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway
Journal of Medicinal Chemistry 2015.0
Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines
European Journal of Medicinal Chemistry 2013.0
Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells
European Journal of Medicinal Chemistry 2018.0
Design, synthesis, and biological evaluation of β-carboline 1,3,4-oxadiazole based hybrids as HDAC inhibitors with potential antitumor effects
Bioorganic & Medicinal Chemistry Letters 2022.0